Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
King
King is currently an MD student at Harvard. He earned his BA in Sociology and Health from University Notre Dame, and earned a MS in Global Public Health and Policy at Queen Mary University of London.
Entela
Entela earned her PhD in Molecular and Cellular Biology (Harvard) and her BS in Biochemistry and Molecular Biology (Clark, summa cum laude, Phi Beta Kappa). Currently, she is the instructor for the Introductory Biology Class at MIT.